Key result
HeartMate II CF-LVAD provides safe, durable hemodynamic support exceeding 5 years in advanced HF.
Why the study?
Does the HeartMate II CF-LVAD provide safe and durable circulatory support for greater than 5 years in patients with advanced heart failure?
Case Report (n=4)
No
Does the HeartMate II CF-LVAD provide safe and durable circulatory support for greater than 5 years in patients with advanced heart failure?
The HeartMate II CF-LVAD can provide safe, durable circulatory support with enhanced quality of life for over 5 years in patients with advanced heart failure.
Supports extended durability in select advanced HF cases; hypothesis-generating and should not yet change practice.
Continuous-flow left ventricular assist devices (CF-LVAD) are now providing years of safe circulatory support with enhanced quality of life. We present four cases of patients with advanced heart failure who received support for greater than 5-years with the HeartMate II CF-LVAD. One patient continues with support at 7.5 years and has decided to not undergo cardiac transplantation. Another patient has also had LVAD support for 7.7 years, initially with a pulsatile flow LVAD, and then was switched to the HeartMate II, which has continued to support him for the last 6.6 years. Two other patients have undergone heart transplant after support times of 5.46 years and 5.75 years. Few complications occurred and the patients had very active lifestyles during support. Explant analysis revealed very low bearing wear and minimal pannus.
No takes yet. Share an insight, caveat, or question.
Schmitto et al. (2015) conducted a case report in Advanced heart failure (n=4). HeartMate II CF-LVAD was evaluated on Long-term survival and device durability. The HeartMate II continuous-flow left ventricular assist device provided safe and durable hemodynamic support exceeding 5 years in four patients with advanced heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: